Newsroom
Latest News
U.S. Rep. Diana DeGette released her blueprint for a "Cures 2.0" bill, an update to the 21st Century Cures Act of 2016 that would address clinical trials, modernization of the U.S. Food & Drug Administration, and pandemic preparedness in the future.
"We've seen a record number of new drugs approved, including new generics, which have helped lower health care costs for millions of Americans. And we're on the cusp of finding a cure for sickle cell," said DeGette and her co-sponsor Rep. Fred Upton, R-Mich. "But despite these successes, there's still much more work to be done."
Second to eliminating the coronavirus altogether, one of the most important things we, as a nation, can do to improve the public health during this unprecedented pandemic is improve air quality.
Nearly a million Americans have now tested positive for coronavirus – a respiratory disease that is wreaking havoc on the lungs of those infected.
But that's not all. Early evidence suggests that people with damaged lungs may be more vulnerable to the disease. Doctors also fear that coronavirus may have long-term negative impacts on our lungs.
The HHS would have to develop a national strategy for beefing up the nation's ability to spot and test for Covid-19 as well as future outbreaks, under a proposal from two lawmakers looking to follow up on their landmark biomedical innovation law.
Donning masks and voting in small groups to avoid close contact, most members of Colorado's congressional delegation voted Thursday to approve a nearly half-trillion-dollar bill in response to the coronavirus pandemic and economic downturn.
The bill was approved in the U.S. House by a vote of 388-5, with one "present" vote. Within the Colorado delegation, all four Democrats voted in favor, along with two Republicans. Rep. Ken Buck was the lone Coloradan to vote nay on the bill.
FIRST IN PULSE: DEMS SEEK ANSWERS OVER WHO FUNDING HALT— Top House Energy and Commerce Committee Democrats are demanding details on Trump's announcement he will suspend funding to the World Health Organization, arguing there is "no justification" for the move.
"It is also a blatant attempt to scapegoat WHO for the Trump Administration's own failures in its response to the global pandemic," Energy and Commerce Chair Frank Pallone and subcommittee chairs Anna Eshoo and Diana DeGette wrote in a letter to OMB Acting Director Russell Vought.